The innovative prosthetic urology portfolio from Rigicon® receives marketing approval in Australia
Rigicon Inc., with its global headquarters in NY, USA, announces that their innovative prosthetic urology portfolio received marketing approval from Australia (Australian Government Department of Health Therapeutic Goods Administration)